The HPV vaccine is a vaccine that provides protection against Human Papillomavirus (HPV), one of the most common sexually transmitted infections worldwide. In order to develop protective immunity against the virus that is directly associated with cervical cancer in particular, as well as anogenital cancers and the formation of genital warts, the HPV vaccine is administered to both women and men within specific age ranges.
What Is the HPV Vaccine?
The HPV vaccine is a vaccine developed to protect against infections caused by Human Papillomavirus (HPV) and the conditions these infections may lead to, such as cervical cancer, genital warts, and other anogenital cancers.
The vaccine provides protection by introducing virus-like particles into the body rather than the actual virus. These particles mimic the outer protein shell of HPV; however, since they do not contain genetic material, they do not have the capacity to cause infection. The immune system recognizes these particles and produces protective antibodies. Thus, when the person encounters the actual virus, the body will already have generated an immune response that can rapidly recognize and neutralize the virus.
HPV vaccines differ according to the number of HPV types they cover. Today, the nine-valent HPV vaccine (9vHPV), which offers the broadest range of protection, is effective against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. These nine types are held responsible for approximately 90% of cervical cancers and for the majority of genital warts.
Who Should Receive the HPV Vaccine?
The HPV vaccine can be administered to children, adolescents, and adults, depending on age, sex, and individual health assessments.
The HPV vaccine may be considered as part of routine vaccination for children aged 9–14. For individuals aged 15–45, vaccine suitability may be evaluated individually based on age, health status, and medical history.
Who Should Not Receive the HPV Vaccine?
As with any vaccine, there are situations in which the HPV vaccine should not be administered. In some special circumstances, HPV vaccination may be postponed or may require physician assessment.
These include:
-
Individuals with known allergy to any component of the vaccine.
-
Women who are pregnant.
-
Individuals who have a fever or an acute illness on the day of vaccination.
-
Individuals who have had a severe allergic reaction (anaphylaxis) to a previous dose of the HPV vaccine.
These circumstances may differ from one individual to another.
When Should the HPV Vaccine Be Given?
Although the HPV vaccine can be considered for different age groups, the timing of administration may be important in terms of the immune response produced by the body. For this reason, the ideal age range for vaccination has been determined as 9–14 years. However, this does not mean that adults cannot benefit from the vaccine. Individuals aged 15–45 years can also receive the vaccine after consulting a physician; in particular, additional protection can be provided against HPV types to which the person has not yet been exposed.
How Many Doses of the HPV Vaccine Are Needed?
The number of HPV vaccine doses may vary depending on the age at which vaccination is initiated. While two doses are considered sufficient for some age groups, a three-dose schedule is evaluated for some individuals. In particular, the age at which the vaccine is started can be important in terms of the immune response.
HPV Vaccination Between Ages 9–14 (2 Doses)
Because the immune response generated in this age group can be stronger, a two-dose schedule may be used.
The schedule is generally as follows:
-
1st dose,
-
2nd dose approximately 6 months after the first dose
This is how the plan may be structured.
The adequacy of two doses in this age range is associated with the immune system’s more effective response to vaccines.
HPV Vaccination at Age 15 and Above (3 Doses)
In individuals aged 15 years and older, a three-dose schedule may be considered.
The general schedule is:
-
1st dose,
-
2nd dose at month 2,
-
3rd dose at month 6
This is the regimen.
In addition, in certain special conditions that may affect the immune system or in individuals with immunodeficiency, a three-dose schedule may also be considered.
Because the HPV vaccination schedule may vary according to personal health characteristics, assessment should be made on an individual basis.
When Does the HPV Vaccine Start to Provide Protection?
It may take some time for the immune system to mount a response after HPV vaccination. Although an immune response may begin after the first dose, completion of the planned schedule is considered an important part of the process. The duration of this process may vary according to individual characteristics.
What Are the Possible Side Effects of the HPV Vaccine?
Mild and usually short-term side effects may occur in some individuals after the HPV vaccine. These effects are often related to the natural response of the immune system to the vaccine.
As with any vaccination, some transient symptoms that vary from person to person may appear after administration. These symptoms may not occur in every individual and their severity can differ.
Possible side effects include:
-
Pain and tenderness at the injection site,
-
Mild redness,
-
Swelling at the injection site,
-
Feeling tired and fatigued,
-
Mild fever,
-
Muscle or joint pain
may occur.
These symptoms often lessen within a short period. Unexpected or prolonged complaints should be evaluated by a specialist physician.
What Should Be Considered After the HPV Vaccine?
After receiving the HPV vaccine, individuals can continue with their daily activities. However, it is important to monitor any temporary symptoms that may occur at the injection site and to maintain the scheduled dosing plan regularly.
Some individuals may experience mild and short-term reactions after the HPV vaccine. These situations differ from person to person. It may be beneficial to observe overall health status after vaccination and to follow the planned schedule.
Points to consider include:
-
Monitoring for pain, redness, or tenderness at the injection site.
-
Paying attention to adequate fluid intake throughout the day.
-
Resting briefly if dizziness or a feeling of weakness occurs.
-
Evaluating unexpected or prolonged symptoms.
-
Not disrupting the planned dosing schedule.
-
Undergoing relevant health assessments if there is any change in health status.
The effects that may be seen after the HPV vaccine can vary from person to person.
Frequently Asked Questions
Can a person who has received the HPV vaccine stop cervical cancer screening?
No. The HPV vaccine does not provide protection against all HPV types. Therefore, vaccinated individuals should continue to undergo regular cervical cancer screening (Pap smear/HPV test).
Is the HPV vaccine also given to men?
Yes. As in women, the HPV vaccine is also considered for men to induce an immune response against certain HPV types. Men can be vaccinated for both individual protection and community (herd) immunity.
Can individuals who have contracted HPV be vaccinated?
Having encountered HPV does not always mean that a person has been exposed to all HPV types. Therefore, vaccine eligibility can be assessed individually in people with a history of HPV exposure. Since vaccines aim to induce an immune response against specific HPV types, the decision to vaccinate may vary depending on factors such as age, health status, and medical evaluation.
How long does the HPV vaccine provide protection?
Long-term follow-up studies show that the effectiveness of the HPV vaccine continues for at least 10–12 years after vaccination. Research is ongoing regarding the need for a booster dose.
Can the HPV vaccine be administered during pregnancy?
The HPV vaccination plan may vary in special situations such as pregnancy, based on individual evaluation.
